Docetaxel
NDC 0409-0016, DOCETAXEL ANHYDROUS, injection, solution, from Hospira, Inc..
- Product NDC
- 0409-0016
- Status
- Listed
- Labeler
- Hospira, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022234
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0409-0016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOCETAXEL ANHYDROUS10 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0409-0016-01 | 00409001601 | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-0016-01) / 16 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/00c61d11-d6b7-4618-b6f6-2592dbcc8af7Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0409-0016
Use it
Look up 0409-0016 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0409-0016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0409-0016. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.